rhopressa的多重作用机制(图片来源:aerie pharmaceuticals)
基于rhopressa的两项3期临床试验rocket 2和rocket 1的结果,aerie于
青光眼药物rhopressa的生产线正在接受美国食品与药物管理局(fda)调查
aerie pharmaceuticals宣布,美国fda认为其青光眼药物rhopressa总体
重仓rock抑制剂|青光眼|aerie|眼科|全球|rhopressa|-健康界
Tips:Do Not Provide
Personal Loans: Go Easy On Your Finances
Finance, Finance, Finance, Foreign Exchange, Stocks, Currency Circle, Venture Capital, Bitcoin, ICO...